2,194 followers
@PersimmonTI $MREO acumapimod intriguing also. Still wholly-owned. https://t.co/PFvTXUnrLY
2,194 followers
Apart from its TIGIT asset, $MREO has 3 other wholly-owned candidates. One of them is acumapimod, an oral p38 MAP kinase inhibitor. Acumapimod is discussed in this March 2021 article on COPD below. https://t.co/sQ43HxRpNx https://t.co/NU57Z1dBci